PROPHYLOCHIP: no benefit of second-look surgery plus HIPEC for colorectal peritoneal metastases. - National Genomics Data Center (CNCB-NGDC)

Advanced Search

PROPHYLOCHIP: no benefit of second-look surgery plus HIPEC for colorectal peritoneal metastases.

Brendan J Moran

Author Information

Brendan J Moran: Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Basingstoke, RG24 9NA, UK. Electronic address: brendan.moran@hhft.nhs.uk.

PMID: 32717181 DOI: 10.1016/S1470-2045(20)30338-7

No abstract text available.

Colorectal Neoplasms

Humans

Hyperthermia, Induced

Peritoneal Neoplasms

Second-Look Surgery

Journal Article Comment

Initial Experience of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Baltic Country Center.Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal malignancy: initial experience of the first program in the Baltic countries.Actual survival after resection of primary colorectal cancer: results from a prospective multicenter study.Prediction of Metachronous Peritoneal Metastases After Radical Surgery for Colon Cancer: A Scoring System Obtained from an International Multicenter Cohort.Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).